You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 9, September 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Images in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Immunologic Disorders
 •Multiple Sclerosis/ Demyelinating Disease
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Demyelinating Pseudotumor

Arch Neurol. 2005;62:1466-1467.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A case of demyelinating pseudotumor, considered an acute fulminant variant of multiple sclerosis (MS), occurring in a patient with definite MS is presented. Magnetic resonance imaging (MRI) showed a large, biopsy-proven demyelinating lesion with ring enhancement and mass effect. Treatment resistance to corticosteroids and {beta}-interferons occurred, which prompted our present use of combined corticosteroids/plasmapheresis followed by mitoxantrone.

A 50-year-old Caucasian man presented with acute onset confusion, inappropriate speech, and forgetfulness, as well as depressive symptoms for the preceding 2 years. On neurological examination, disorientation, a right lower facial paresis, and symmetrical hyperreflexia were present, but there was no papilledema or Babinski response probably owing to the acuteness of this process. Axial T1-weighted postgadolinium images (Figure 1) and fluid-attenuated inversion recovery MRI (Figure 2) show a left hemisphere contrast-enhancing ring lesion with massive edema and midline shift, and smaller typical MS lesions in the right hemisphere (and . . . [Full Text of this Article]

AUTHOR INFORMATION

Stephen L. Jaffe, MD; Alireza Minagar, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.